| Serial Number | 98746955 |
| Word Mark | ADAPTIN BIO |
| Filing Date | Thursday, September 12, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, August 7, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 26, 2025 |
| Description of Mark | The mark consists of the word "ADAPTIN" in all lowercase, with an empty diagonal arrow going through the second "A" pointing toward the top right followed by the word "BIO" in all capital letters. |
| Goods and Services | Biological preparations for treatment of cancers, central nervous system diseases and autoimmune disorders; Medical preparations and pharmaceuticals for treatment of cancers, central nervous system diseases and autoimmune disorders; Drug delivery agents in the form of an injectable liquid suspension that facilitate delivery of pharmaceutical preparations; Drug delivery platform, namely, drug delivery agents in the nature of cellular products being an injectable liquid suspension that facilitates delivery of pharmaceuticals; Pharmaceutical preparations for the treatment of cancers, central nervous system diseases and autoimmune disorders using compounds comprising of manipulated immune cells |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Biological preparations for use in the manufacture of pharmaceuticals |
| NOT AVAILABLE | "BIO" |
| Goods and Services | Research in the field of biotechnology and pharmaceutical development; Research and development of platform technologies for delivery of therapies; Research and development of platform technologies for delivery of antibody therapies, cell therapies and pharmaceuticals; Research and development regarding the use of immune system cells to discover, research and develop novel platform technologies for delivery of therapies and pharmaceuticals; Pharmaceutical research and development for the treatment of cancers, neurological diseases, and neurological disorders and autoimmune disorders; Scientific research in the field of drug delivery platforms, cell therapies and pharmaceuticals; Pharmaceutical research services; Research and development of pharmaceutical preparations for treatment of cancers, neurological diseases and disorders and autoimmune diseases; Research and development in the fields of pharmaceuticals and biotechnology; Research and development regarding the delivery of drug therapies across the blood-brain barrier and other physiological barriers; Research and development regarding the delivery of drug and cell therapies to targeted body tissue; Research and development regarding the identification and targeting of specific cells for drug therapies |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Adaptin Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Charlotte, NC 28277 |
| Event Date | Event Description |
| Thursday, September 12, 2024 | NEW APPLICATION ENTERED |
| Friday, March 14, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, March 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 14, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, April 1, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 1, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 1, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 1, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 18, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, July 18, 2025 | FINAL REFUSAL WRITTEN |
| Friday, July 18, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, July 23, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 23, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 23, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 23, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, August 20, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 1, 2025 | NON-FINAL ACTION E-MAILED |